Julie K. Andersen

15.8k total citations · 4 hit papers
169 papers, 12.4k citations indexed

About

Julie K. Andersen is a scholar working on Neurology, Molecular Biology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Julie K. Andersen has authored 169 papers receiving a total of 12.4k indexed citations (citations by other indexed papers that have themselves been cited), including 78 papers in Neurology, 62 papers in Molecular Biology and 53 papers in Cellular and Molecular Neuroscience. Recurrent topics in Julie K. Andersen's work include Parkinson's Disease Mechanisms and Treatments (71 papers), Genetics, Aging, and Longevity in Model Organisms (22 papers) and Alzheimer's disease research and treatments (22 papers). Julie K. Andersen is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (71 papers), Genetics, Aging, and Longevity in Model Organisms (22 papers) and Alzheimer's disease research and treatments (22 papers). Julie K. Andersen collaborates with scholars based in United States, United Kingdom and Australia. Julie K. Andersen's co-authors include Shankar J. Chinta, Anand Rane, Subramanian Rajagopalan, Deepinder Kaur, Jun Peng, Judith Campisi, Michael Hsu, Fang Feng Stevenson, Jyothi K. Mallajosyula and Donato A. Di Monte and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Nature Medicine.

In The Last Decade

Julie K. Andersen

168 papers receiving 12.2k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Oxidative stress in neurodegeneration: cause or consequence?

2004 1.5k citations Julie K. Andersen profile →
Mice Deficient in Cellular Glutathione Peroxidase Show Increased Vulnerability to Malonate, 3-Nitropropionic Acid, and 1-Methyl-4-Phenyl-1,2,5,6-Tetrahydropyridine

2000 980 citations Julie K. Andersen, Dongmei Jiang et al. Journal of Neuroscience profile →
Genetic or Pharmacological Iron Chelation Prevents MPTP-Induced Neurotoxicity In Vivo

2003 526 citations Subramanian Rajagopalan, Julie K. Andersen et al. profile →
Cellular Senescence Is Induced by the Environmental Neurotoxin Paraquat and Contributes to Neuropathology Linked to Parkinson’s Disease

2018 378 citations Shankar J. Chinta, Anand Rane et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Julie K. Andersen United States	54	4.9k	3.3k	2.9k	2.8k	1.7k	169	12.4k
Frédéric Calon Canada	63	3.6k 0.7×	2.7k 0.8×	3.4k 1.2×	4.1k 1.5×	1.8k 1.0×	192	11.8k
Donato A. Di Monte United States	67	3.7k 0.8×	7.2k 2.2×	5.1k 1.7×	2.7k 1.0×	2.1k 1.2×	167	13.7k
Kim Tieu United States	37	4.1k 0.8×	3.7k 1.1×	3.0k 1.0×	2.5k 0.9×	2.6k 1.5×	62	10.8k
Rajiv R. Ratan United States	68	8.7k 1.8×	1.6k 0.5×	3.2k 1.1×	2.4k 0.9×	1.9k 1.1×	164	15.4k
David T. Dexter United Kingdom	58	5.7k 1.2×	7.6k 2.3×	5.1k 1.7×	3.2k 1.2×	3.2k 1.8×	136	16.4k
Diogo O. Souza Brazil	67	6.0k 1.2×	1.4k 0.4×	4.9k 1.7×	3.0k 1.1×	2.6k 1.5×	602	18.6k
James P. Bennett United States	53	5.6k 1.1×	2.7k 0.8×	4.4k 1.5×	2.3k 0.8×	995 0.6×	163	10.5k
Andrey Y. Abramov United Kingdom	73	9.3k 1.9×	3.6k 1.1×	3.3k 1.1×	5.3k 1.9×	2.4k 1.4×	208	17.9k
Gary E. Gibson United States	64	6.2k 1.3×	2.7k 0.8×	3.2k 1.1×	5.1k 1.9×	1.2k 0.7×	234	13.5k
Gang Hu China	68	7.7k 1.6×	1.9k 0.6×	3.9k 1.3×	2.2k 0.8×	3.1k 1.8×	379	16.3k

Countries citing papers authored by Julie K. Andersen

Since Specialization

Citations

This map shows the geographic impact of Julie K. Andersen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Julie K. Andersen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Julie K. Andersen more than expected).

Fields of papers citing papers by Julie K. Andersen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Julie K. Andersen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Julie K. Andersen. The network helps show where Julie K. Andersen may publish in the future.

Co-authorship network of co-authors of Julie K. Andersen

This figure shows the co-authorship network connecting the top 25 collaborators of Julie K. Andersen. A scholar is included among the top collaborators of Julie K. Andersen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Julie K. Andersen. Julie K. Andersen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Chamoli, Manish, et al.. (2025). Mitigating Pro‐Inflammatory SASP and DAMP With Urolithin A: A Novel Senomorphic Strategy. Aging Cell. 24(11). e70237–e70237.

Chamoli, Manish, Anand Rane, Anna Foulger, et al.. (2023). A drug-like molecule engages nuclear hormone receptor DAF-12/FXR to regulate mitophagy and extend lifespan. Nature Aging. 3(12). 1529–1543. 20 indexed citations

Sivapatham, Renuka, et al.. (2022). Urolithin A reduces amyloid-beta load and improves cognitive deficits uncorrelated with plaque burden in a mouse model of Alzheimer’s disease. GeroScience. 45(2). 1095–1113. 37 indexed citations

Khanna, Amit, Durai Sellegounder, Jitendra Kumar, et al.. (2021). Trimethylamine modulates dauer formation, neurodegeneration, and lifespan through tyra‐3/daf‐11 signaling in Caenorhabditis elegans. Aging Cell. 20(5). e13351–e13351. 3 indexed citations

Angeli, Suzanne, Anna Foulger, Manish Chamoli, et al.. (2021). The mitochondrial permeability transition pore activates the mitochondrial unfolded protein response and promotes aging. eLife. 10. 36 indexed citations

Xie, Xueshu, Manish Chamoli, Dipa Bhaumik, et al.. (2020). Quantification of Insoluble Protein Aggregation in <em>Caenorhabditis elegans</em> during Aging with a Novel Data-Independent Acquisition Workflow. Journal of Visualized Experiments. 26–27. 4 indexed citations

Siddiqui, Almas, Dipa Bhaumik, Shankar J. Chinta, et al.. (2015). Mitochondrial Quality Control via the PGC1α-TFEB Signaling Pathway Is Compromised by Parkin Q311X Mutation But Independently Restored by Rapamycin. Journal of Neuroscience. 35(37). 12833–12844. 103 indexed citations

Aleyasin, Hossein, Saravanan S. Karuppagounder, Amit Kumar, et al.. (2014). Antihelminthic Benzimidazoles Are Novel HIF Activators That Prevent Oxidative Neuronal Death via Binding to Tubulin. Antioxidants and Redox Signaling. 22(2). 121–134. 17 indexed citations

Siddiqui, Almas, Anand Rane, Carlos A. Torres‐Ramos, et al.. (2012). Mitochondrial DNA damage Is associated with reduced mitochondrial bioenergetics in Huntington's disease. Free Radical Biology and Medicine. 53(7). 1478–1488. 117 indexed citations

10.

Campisi, Judith, Julie K. Andersen, Pankaj Kapahi, & Simon Melov. (2011). Cellular senescence: A link between cancer and age-related degenerative disease?. Seminars in Cancer Biology. 21(6). 354–9. 322 indexed citations

11.

Siddiqui, Almas, Jyothi K. Mallajosyula, Anand Rane, & Julie K. Andersen. (2011). Ability to delay neuropathological events associated with astrocytic MAO-B increase in a Parkinsonian mouse model: Implications for early intervention on disease progression. Neurobiology of Disease. 43(2). 527–532. 14 indexed citations

12.

Kim, Yong‐Hwan, Anand Rane, Stephanie Lussier, & Julie K. Andersen. (2011). Lithium protects against oxidative stress‐mediated cell death in α‐synuclein‐overexpressing in vitro and in vivo models of Parkinson's disease. Journal of Neuroscience Research. 89(10). 1666–1675. 47 indexed citations

13.

Danielson, Steven R., et al.. (2011). Quantitative Mapping of Reversible Mitochondrial Complex I Cysteine Oxidation in a Parkinson Disease Mouse Model. Journal of Biological Chemistry. 286(9). 7601–7608. 53 indexed citations

14.

Chinta, Shankar J., Anand Rane, Nagendra Yadava, et al.. (2009). Reactive oxygen species regulation by AIF- and complex I-depleted brain mitochondria. Free Radical Biology and Medicine. 46(7). 939–947. 50 indexed citations

15.

Peng, Jun, Lei Peng, Fang Feng Stevenson, Susan R. Doctrow, & Julie K. Andersen. (2007). Iron and Paraquat as Synergistic Environmental Risk Factors in Sporadic Parkinson's Disease Accelerate Age-Related Neurodegeneration. Journal of Neuroscience. 27(26). 6914–6922. 112 indexed citations

16.

Mythri, Rajeswara Babu, Jyothi Padiadpu, Krishnan Ramanujan, et al.. (2007). Integrating glutathione metabolism and mitochondrial dysfunction with implications for Parkinson’s disease: A dynamic model. Neuroscience. 149(4). 917–930. 72 indexed citations

17.

Andersen, Julie K.. (2001). Do Alterations in Glutathione and Iron Levels Contribute to Pathology Associated with Parkinson's Disease?. Novartis Foundation symposium. 235. 11–25. 16 indexed citations

18.

Andersen, Julie K.. (2001). Does neuronal loss in Parkinson's disease involve programmed cell death?. BioEssays. 23(7). 640–646. 56 indexed citations

19.

Jiang, Dongmei, Garnik Akopian, Ye‐Shih Ho, John P. Walsh, & Julie K. Andersen. (2000). Chronic Brain Oxidation in a Glutathione Peroxidase Knockout Mouse Model Results in Increased Resistance to Induced Epileptic Seizures. Experimental Neurology. 164(2). 257–268. 35 indexed citations

20.

Andersen, Julie K.. (2000). What causes the build-up of ubiquitin-containing inclusions in Parkinson’s disease?. Mechanisms of Ageing and Development. 118(1-2). 15–22. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact